Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Retatrutide is a triple GLP-1, GIP, and glucagon receptor agonist under clinical investigation for obesity, but it is not licensed by the MHRA or EMA in the UK
The peptide has been studied for its ability to mimic some of the fat-burning activities of HGH without causing growth hormone-like side effects
Standard 2ml ratio works well
Opting for needles made from high-quality materials ensures safety during the injection process
Can melasma spread to other parts of the body
US$ 29.51
US$ 26.40
US$ 29.58
